 |
Henry M. Kronenberg, M.D. is Chief of the Endocrine Unit at the Massachusetts General Hospital and Professor of Medicine at the Harvard Medical School. There he leads a research group that studies the actions of parathyroid hormone and parathyroid hormone-related protein, with a particular emphasis on bone development, bone biology, calcium homeostasis and osteoblastic support of hematopoiesis. Dr. Kronenberg’s laboratory in recent years has used a number of genetically altered strains of mice to establish the role of signaling by the PTH/PTHrP receptor in bone.
Dr. Kronenberg received his BA from Harvard University, his MD from Columbia University, his medical house officer training at the Massachusetts General Hospital, and post-doctoral training at NIH, MIT, and the MGH.
Dr.
Kronenberg has won the Fuller Albright Young Investigator Award and the William F. Neuman Award and delivered the Avioli Memorial Lecture of the American Society for Bone and Mineral Research. He received the Gerald D. Aurbach Lecture Award of the Endocrine Society. He also received the Harold Copp Award of the International Bone and Mineral Society. He has served as President of the American Society for Bone and Mineral Research and as a member of the Board of Directors of the International Bone and Mineral Society. He has served on the Council of the Endocrine Society, as the Endocrine Society’s member on the FASEB Science Policy Committee, and is currently Vice President for Basic Science and FASEB Board representative. He has served on the General Medicine B NIH Study Section and currently serves as a member of the Board of Scientific Counselors of the National Institute of Dental and Craniofacial Research. He is a member of the American Society for Clinical Investigation and the Association of American Physicians.
|
